|
|
Volumn 40, Issue SUPPL. 1, 2001, Pages 49-55
|
|
Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CATION;
MOXIFLOXACIN;
SUCRALFAT RATIOPHARM 1000;
SUCRALFATE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CHELATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SOLUBILITY;
DRUG TOLERABILITY;
DRUG URINE LEVEL;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ACCIDENTAL INJURY;
COMBINATION DRUG THERAPY;
ELIMINATION HALF-LIFE;
FACE DISORDER;
FECES;
HYPESTHESIA;
INTESTINAL DYSMOTILITY;
LITTLE FINGER;
MAXIMUM CONCENTRATION;
MEAN RESIDENCE TIME;
MONOTHERAPY;
ORAL CLEARANCE;
PERISTALSIS;
PLASMA CONCENTRATION-TIME CURVE;
PRURITUS;
RENAL CLEARANCE;
REPEATED DRUG DOSE;
RING FINGER;
SIDE EFFECT;
SINGLE DRUG DOSE;
SORE THROAT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
|
|
EID: 0035068866
PISSN: 03125963
EISSN: None
Source Type: Journal
DOI: 10.2165/00003088-200140001-00007 Document Type: Article |
|
Times cited : (18)
|
|
References (3)
|
